Image

Global Uterine Fibroid Embolization Devices Market – Industry Trends and Forecast to 2029

Healthcare

Image

Global Uterine Fibroid Embolization Devices Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Uterine Fibroid Embolization Devices Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 5.01 Billion
Diagram Market Size (Forecast Year) USD 7.08 Billion
Diagram CAGR %

Global Uterine Fibroid Embolization Devices Market, By Technology (Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment) – Industry Trends and Forecast to 2029.

Uterine Fibroid Embolization Devices Market

Global Uterine Fibroid Embolization Devices Market Analysis and Size

In recent years, Uterine fibroid embolization (UFE) have been highly deployed globally due to its minimally invasive technique. The technique incorporates the use of a real-time x-ray called fluoroscopy to guide the delivery of embolic agents to the uterus and fibroids. About 90% of women who have undergone UFE experience significant or complete resolution of their fibroid-related symptoms.

  • Global Uterine Fibroid Embolization Devices Market was valued at USD 5.01 billion in 2021 and is expected to reach USD 7.08 billion by 2029, registering a CAGR of 4.40% during the forecast period of 2022-2029. “The minimally invasive treatment” accounts for the largest mode of treatment segment in the respective market owing to the high awareness regarding the technique among people.

Global Uterine Fibroid Embolization Devices Market Definition

Uterine fibroid embolization (UFE) refers to a minimally invasive treatment that is widely utilized for treating fibroid tumors in the uterus. The procedure is referred as a uterine artery embolization (UAE), and is used for treating other complications such as placenta previa, arteriovenous malformations of the pelvis and placenta accrete.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Technology (Surgical Techniques, Laparoscopic Techniques, Ablation Techniques, Embolization Techniques), Mode of Treatment (Invasive Treatment, Minimally Invasive Treatment, Non-Invasive Treatment)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

Boston Scientific Corporation (US), Merit Medical Systems (US), BioSpace (US), Hologic, Inc. (US), Cook (UK), Ferring B.V. (Switzerland), Smith+Nephew (UK), CooperSurgical, Inc. (US), Aetna Better Health of Pennsylvania (US), Ethicon US, LLC (US), Olympus America (US), Stryker (US), among others

Market Opportunities

  • Rise in the prevalence of uterine fibroids
  • Increase in the preference for minimally invasive surgery
  • Advancements in the procedure

Uterine Fibroid Embolization Devices Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:

  • Prevalence of Uterine Fibroids

The rise in the prevalence of uterine fibroids among women across the acts as one of the major factors driving the growth of uterine fibroid embolization devices market.

  • Preference for Minimally Invasive Surgery

The increase in the preference for minimally invasive surgery owing to the advantages, such as smaller incisions decrease post-operative pain and speedy recovery, accelerate the market growth.

  • Increase in Funds

The surge in funding from private and government organizations for development of healthcare sector and research centers further influence the market.

Opportunities

Furthermore, advancements in the procedure and devices devices extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, rise in healthcare awareness among the patients will further expand the market.

Restraints/Challenges Global Uterine Fibroid Embolization Devices Market

On the other hand, high cost of medical devices and ongoing healthcare reforms are expected to obstruct market growth. Also, stringent regulations are projected to challenge the uterine fibroid embolization devices market in the forecast period of 2022-2029.

This uterine fibroid embolization devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on uterine fibroid embolization devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Covid-19 Impact on Uterine Fibroid Embolization Devices Market

COVID-19 had a negative impact on the uterine fibroid embolization devices market owing to the decline in elective surgeries. Hospital access was restricted to non-essential care, and O&P clinics were temporarily closed during the pandemic. The implementation of social distancing, lockdown of the population and limited access to clinics greatly affected the market. The slow-down in patient flow and referrals, and decline in trauma and workplace injuries also impacted the market growth. However, market will resume its growth in the post-pandemic due to the easing in restrictions that were imposed earlier.

Recent Development

  • Karl Storz has launched Tele Pack+, a compact endoscopy system in March’2020. The system is a transportable video system that assists in merging all of the key components, such as light source, display and camera control unit together required for diagnosis and treatment.
  • Gynesonics, developed Sonata System in July’2020. The system is transcervical fibroid ablation system that makes use of radiofrequency energy for treating symptomatic uterine fibroids. The system detects and then target a single fibroid with a combination of radiofrequency and ultrasound.

Global Uterine Fibroid Embolization Devices Market Scope and Market Size

The uterine fibroid embolization devices market is segmented on the basis of technology and mode of treatment. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

  • Surgical Techniques
  • Laparoscopic Techniques
  • Ablation Techniques
  • Embolization Techniques

Based on technology, uterine fibroid embolization devices market is segmented into surgical techniques, laparoscopic techniques, ablation techniques and embolization techniques. Surgical techniques have been further segmented into hysterectomy and myomectomy. Laparoscopic Techniques have been further segmented into laparoscopic myomectomy and myolysis. Ablation Techniques have been further segmented into microwave ablation, hydrothermal ablation, cryoablation, ultrasound ablation and other ablation techniques. Ultrasound ablation is segmented into high-intensity focused ultrasound (HIFU) and MRI-guided focused ultrasound (MRGFUS).

Mode of Treatment

  • Invasive Treatment
  • Minimally Invasive Treatment
  • Non-Invasive Treatment

Uterine fibroid embolization devices market has also been segmented based on the mode of treatment into invasive treatment, minimally invasive treatment and non-invasive treatment.

Uterine Fibroid Embolization Devices Market Regional Analysis/Insights

The uterine fibroid embolization devices market is analysed and market size insights and trends are provided by country, technology and mode of treatment as referenced above.

The countries covered in the uterine fibroid embolization devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the uterine fibroid embolization devices market because of the presence of well-established healthcare facilities within the region.

Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the large patient base and unmet needs regarding the fibroids diagnosis and treatment in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The uterine fibroid embolization devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for uterine fibroid embolization devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the uterine fibroid embolization devices market. The data is available for historic period 2010-2020.

Competitive Landscape and Uterine Fibroid Embolization Devices Market Share Analysis

The uterine fibroid embolization devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to uterine fibroid embolization devices market.

Some of the major players operating in the uterine fibroid embolization devices market are

  • Boston Scientific Corporation (US)
  • Merit Medical Systems (US)
  • BioSpace (US)
  • Hologic, Inc. (US)
  • Cook (UK)
  • Ferring B.V. (Switzerland)
  • Smith+Nephew (UK)
  • CooperSurgical, Inc. (US)
  • Aetna Better Health of Pennsylvania (US)
  • Ethicon US, LLC (US)
  • Olympus America (US)
  • Stryker (US)

Research Methodology : Global Uterine Fibroid Embolization Devices Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-uterine-fibroid-embolization-devices-market


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Uterine Fibroid Embolization Devices Market is expected USD 7.08 billion by 2029.
The Uterine Fibroid Embolization Devices Market is Expected to Witness CAGR of 4.40% During the Forecast Period of 2022 to 2029.
The Major Players Operating in the Uterine Fibroid Embolization Devices Market are Boston Scientific Corporation (US), Merit Medical Systems (US), BioSpace (US), Hologic, Inc. (US), Cook (UK), Ferring B.V. (Switzerland), among others.
The Countries Covered in the Uterine Fibroid Embolization Devices Market Report are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
The Uterine Fibroid Embolization Devices Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials